Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SECURE: Twirla contraceptive patch efficacy study
NCT02158572Phase 3Completed
- Sponsor
- Agile Therapeutics
- Start
- Aug 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of ethinyl estradiol + levonorgestrel in contraception, sponsored by Agile Therapeutics. Primary endpoint: Contraception Efficacy (Pearl Index) in Subjects ≤ 35 Years of Age at 1 year. Started Aug 2014; status: completed.
02
Drugs
ethinyl estradiol + levonorgestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02158572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02158572.